Related references
Note: Only part of the references are listed.Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation
Robert M. Harmon et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development
D. H. Siegel et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Desmosomes: new perpetrators in tumour suppression
Rachel L. Dusek et al.
NATURE REVIEWS CANCER (2011)
The Scaffold Protein Shoc2/SUR-8 Accelerates the Interaction of Ras and Raf
Rie Matsunaga-Udagawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis
Spiro Getsios et al.
JOURNAL OF CELL BIOLOGY (2009)
Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies
Ken Ishii et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway:: genotype-phenotype relationships and overlap with Costello syndrome
Caroline Nava et al.
JOURNAL OF MEDICAL GENETICS (2007)
Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes
Donna Brennan et al.
JOURNAL OF CELL SCIENCE (2007)
Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome
John R. Stanley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Comparative analysis of the expression of ERBIN and Erb-B2 in normal human skin and cutaneous carcinomas
S Lebeau et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Striate palmoplantar keratoderma arising from desmoplakin and desmoglein 1 mutations is associated with contrasting perturbations of desmosomes and the keratin filament network
H Wan et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Desmoglein isoform distribution affects stratum corneum structure and function
PM Elias et al.
JOURNAL OF CELL BIOLOGY (2001)
Protection against pemphigus foliaceus by desmoglein 3 in neonates.
H Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Expression of desmoglein I and plakoglobin in skin carcinomas
H Tada et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2000)